Mutual Fund Insights: Alger Health Sciences B Fund (AHSBX)

In-depth Analysis of Alger Health Sciences B Fund (AHSBX)

3 months 6 months 1 year 3 year 5 year

See Alger Health Sciences B Fund (AHSBX) performance details as of February 28, 2010

  

Last Trade: $17.25 on 3/19/2010, Change: -0.04 (-0.23%)

  

Fund Manager - Rosanne C. Ott

Fund Manager Tenure: 4.5 years   [Similar Funds: AHSAX  AHSCX ]
Fundmojo Fund Grade: B (Score: 0.68)     (What does this score mean?)

Rosanne C. Ott has spent the last seven years as an equity research analyst in the health care sector. Rosanne C. Ott joined Alger in April 2002 as vice president and senior analyst, covering medical supplies and device sectors. Rosanne C. Ott also covers a deathcare/funeral home services as well as pharmaceuticals and biotech. Rosanne C. Ott was previously at Lehman Brothers and Piper Jaffray as an equity research analyst covering medical supplies and devices.  Get more insights on Rosanne C. Ott

  

 What we like about Alger Health Sciences B Fund (AHSBX)

Data for Alger Health Sciences B Fund (AHSBX) as of February 28, 2010

• Alger Health Sciences B Fund (AHSBX) management has been with Alger Health Sciences B Fund for 4.5 years
• Alger Health Sciences B Fund (AHSBX) has good short-term performance (1-year return 40.91% vs 40.03 % Health category average)
• Alger Health Sciences B Fund (AHSBX) has good mid-term performance (3-year return 1.62% vs 0.87 % Health category average)
• Alger Health Sciences B Fund (AHSBX) has good Long-term performance (5-year return 6.90% vs 4.77 % Health category average)
• Alger Health Sciences B Fund (AHSBX) ratio of up-years vs down years is greater than 2
• Alger Health Sciences B Fund (AHSBX) has a Morningstar rating of 4 and above
• Alger Health Sciences B Fund (AHSBX) is less volatile than its peers as it has a 3-year Standard Deviation of 17.96, lower than category average of 18.82

  

 What we are cautious about Alger Health Sciences B Fund (AHSBX)

Data for Alger Health Sciences B Fund (AHSBX) as of February 28, 2010

• Alger Health Sciences B Fund is a focused fund with 33.58% of the portfolio on top 10 securities. This tends to produce more volatility compared to a diversified fund. See fund top 10 holdings.
• Alger Health Sciences B Fund (AHSBX) is less safe compared to its Health peers
• Alger Health Sciences B Fund (AHSBX) has an annual stock turnover rate of 174.56% that is higher than the Health average of 169.11%. This could mean Alger Health Sciences B is more nimble, but also signal potential high tax impact and high trading fees
• Alger Health Sciences B Fund (AHSBX) has a higher management fee of 2.29% than its Health average of 1.98%
• Alger Health Sciences B Fund (AHSBX) carries a 5% load

See Alger Health Sciences B Fund (AHSBX) performance details as of February 28, 2010

  

  

Interested in other top mutual funds in similar Health category?

Below are some additional Health mutual funds generated out of our database

• Fidelity Select Pharmaceuticals (FPHAX)    [ Compare with Alger Health Sciences B Fund (AHSBX) ]
• BlackRock Health Sciences Ops Inv B (SHSPX)    [ Compare with Alger Health Sciences B Fund (AHSBX) ]
• See top fund managers for Health Category Funds
• Browse other funds in Health Category

  

Alger Health Sciences B Fund (AHSBX) Net Asset

Track net asset change of Alger Health Sciences B fund (AHSBX)

Date	Net Asset
02/2010	$276.98M
01/2010	$18.59M
11/2009	$17.85M

More historic net asset information on Alger Health Sciences B Fund (AHSBX)

  

Alger Health Sciences B Fund (AHSBX) Portfolio Allocation

Track portfolio allocation change of Alger Health Sciences B fund (AHSBX)

Date	Cash	Stock	Bond	Other
11/2009	2.49%	97.51%	0%	0%
08/2009	0.47%	99.54%	0%	0%
07/2009	6.73%	93.27%	0%	0%

Click here to see more historic asset allocation information on Alger Health Sciences B Fund (AHSBX)

  

Most Recent Top 10 Holdings in Alger Health Sciences B Fund (AHSBX)

Discover what Alger Health Sciences B Fund (AHSBX) manager is buying

30-Nov-09 PFIZER INC [4.45%] JOHNSON AND JOHNS DC [3.69%] Human Genome Sciences, Inc. [3.65%] MEDICIS PHARMA CP [3.48%] Auxilium Pharmaceuticals, Inc. [3.36%] INVERNESS MED INNOVA [3.11%] BAXTER INTL INC [3.03%] Celgene Corporation [2.96%] BOSTON SCIENTIFIC CP [2.95%] Optimer Pharmaceuticals, Inc. [2.9%]

31-Aug-09 ABBOTT LABORATORIES [3.62%] Life Technologies Corporation [3.62%] Optimer Pharmaceuticals, Inc. [3.5%] Celgene Corporation [3.42%] PFIZER INC [3.34%] Shire plc [3.24%] BAXTER INTL INC [3.22%] Cephalon, Inc. [3.17%] Auxilium Pharmaceuticals, Inc. [3.1%] MEDICIS PHARMA CP [3.09%]

31-Jul-09 WYETH [4.26%] Optimer Pharmaceuticals, Inc. [3.83%] Life Technologies Corporation [3.74%] Cephalon, Inc. [3.3%] MEDICIS PHARMA CP [3.23%] Celgene Corporation [3.22%] BAXTER INTL INC [3.22%] PFIZER INC [3.22%] Shire plc [2.96%] Roche Holding AG [2.91%]

Click here for Stock Holding Change Map in Alger Health Sciences B Fund (AHSBX)

  

Related books and products to Alger Health Sciences B Fund (AHSBX)

  

Latest News on Alger Health Sciences B (AHSBX)

See what is happening with Alger Health Sciences B Fund (AHSBX)

Yahoo! Finance: RSS feed not found See more news on Alger Health Sciences B Fund (AHSBX)

 

Books and Resources

 

 

See more information on Alger Health Sciences B Fund (AHSBX)

• Alger Health Sciences B Fund Insights
• Alger Health Sciences B Fund Performance Data
• Alger Health Sciences B Fund News
• Alger Health Sciences B Fund Score Explaination
• Alger Health Sciences B Fund Manager Information
• Historic Alger Health Sciences B Fund Asset Allocation Report
• Historic Alger Health Sciences B Fund Top 10 Holding Tracking
• Historic Alger Health Sciences B Fund Asset Under Management Tracking